Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Original Research
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,831 | Dovepress* | 2,605+ | 72 | 2,677 | |
| PubMed Central* | 226 | 79 | 305 | ||
| Totals | 2,831 | 151 | 2,982 | ||
| *Since 28 July 2023 | |||||
View citations on PubMed Central and Google Scholar